Business Wire
17 Feb 2026, 21:05 UTC · 31w ago
Verdict
Headline takes no side. We score GKOS +1.00 across one claim — strongly bullish.
+1.00strongly bullish
More positive than 99% of ticker scores this week
What the story claims
1 claim · scored −1 bearish … +1 bullish
Glaukos Corporation reported record Q4 2025 net sales of $143.1 million, representing a 36% year-over-year increase.
So whatStrong double-digit top-line growth and record revenues typically drive positive valuation adjustments for medical technology companies.
More positive than 99% of claims this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 99% of ticker scores this week
The company reported record net sales with a significant year-over-year increase of 36%.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
1h ago
+45.2%
Price agrees with the score
$154.82 vs $106.64 close before publication (Feb 17) · not market-adjusted
GKOS chart →
